technologynetworks

deCODE Launches deCODE BreastCancer™ Test to Screen for Risk of the Most Common Forms of ...

deCODE genetics has announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can ...
technologynetworks

deCODE Launches deCODE T2™ - A DNA-based Test for Assessing Inherited Risk of Type 2 Diabetes

deCODE Genetics has announced the launch of deCODE T2™, a DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D). deCODE believes ...
EurekAlert!

deCODE BreastCancer launches, genetic test screens for risk of most common breast cancer forms

Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the ...
EDN

H.264 decoder test takes careful planning

The testing of advanced video decoders is a daunting task, considering the greater complexity and nonlinearity of H.264 compared with MPEG-2. Decoding depends on numerous contexts and states that one ...

Decode.Me: Online Integrative Dermatology for Children & Adults

Decode.Me 1.0 is the first online, root cause dermatology platform specialized in chronic skin issues. By uniting ...
Reuters

Iceland's Decode launches heart attack risk test

LONDON, Oct 11 (Reuters) - Icelandic biotech firm Decode Genetics moved deeper into the diagnostics market on Thursday with the launch of a new laboratory test for genetic variations that increase the ...
Medindia

deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset ...

REYKJAVIK, Iceland, Oct. 11 deCODE genetics(Nasdaq: DCGN) today announced the launch of deCODE MI(TM), a referencelaboratory test for variations in the genome (called ...